Gene · 2072
Papers3,434
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,434
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MMEJ repair of breaks at TA repeats maintains ecDNA and cancer fitness. | Nature | 2026 | 42778593 | PubTator, text mining | PubMed |
| Nanoparticle Co-delivery of Microtubule Inhibitors and Cisplatin Overcomes DNA Repair-Mediated Resistance in Head and Neck Cancer. | Mol Cancer Ther | 2026 | 42777141 | PubTator, text mining | PubMed |
| Rad1-Rad10 uses different interfaces to interact with pathway-specific DNA repair factors. | Nucleic Acids Res | 2026 | 42745665 | PubTator, text mining | PubMed |
| Genetic variation and response to platinum chemotherapy in cancer treatment: a review article. | Pharmacogenomics | 2026 | 42725560 | PubTator, text mining | PubMed |
| Ultramutagenesis through Combined Msh2 Depletion and Proofreading-Deficient DNA Polymerase ε Expression Enhances Small-Molecule Target Identification in Forward Genetic Screens. | ACS Chem Biol | 2026 | 42723219 | PubTator, text mining | PubMed |
| XPA confers ability of endonucleases to act processively and to incise damaged nucleosomal DNA. | Exp Biol Med (Maywood) | 2026 | 42643815 | PubTator, text mining | PubMed |
| Genomic landscape of ERCC alterations in breast and gynecological cancers: implications for targeted therapy and VUS reclassification. | Mol Biol Rep | 2026 | 42627456 | PubTator, text mining | PubMed |
| CRISPR Screening Identifies SMARCAL1 and MRN as Modulators of WRN Dependency in MSI-H Colorectal Cancer. | Cancer Res | 2026 | 42484294 | PubTator, text mining | PubMed |
| Ultramutagenesis through combined Msh2 depletion and proofreading-deficient DNA polymerase ε expression enhances small molecule target identification in forward genetic screens. | bioRxiv | 2026 | 42427792 | PubTator, text mining | PubMed |
| Recruitment and release of XPG during NER is controlled by pre- and post-incision factors and EXO1. | J Cell Biol | 2026 | 42377264 | PubTator, text mining | PubMed |
| Diagnostic value of genetic testing in chorea: a retrospective monocentric study. | J Neurol | 2026 | 42321428 | PubTator, text mining | PubMed |
| XPF-like domain in human SHOC1 is required for crossover formation and protecting autosome from MSUC. | Nucleic Acids Res | 2026 | 42258546 | PubTator, text mining | PubMed |
| Determination of copy number variations and affected gene networks in breast cancer. | Biomed Rep | 2026 | 42221547 | PubTator, text mining | PubMed |
| Higher Levels of BRCA1 Gene Methylation in Sporadic Breast Cancer Patients with a Lower Incidence of Recurrence. | Med Sci (Basel) | 2026 | 42201043 | PubTator, text mining | PubMed |
| CIP2A recruits SLX4-MUS81-XPF in mitosis and protects against replication stress. | EMBO Rep | 2026 | 42192029 | PubTator, text mining | PubMed |
| XPF mediates 3' flap processing for FEN1-independent Okazaki fragment maturation. | Nucleic Acids Res | 2026 | 42186816 | PubTator, text mining | PubMed |
| Phosphorylation by CDK1 switches the function of the human SLX4 SAP domain from DNA binding to MUS81 binding. | Nucleic Acids Res | 2026 | 42130070 | PubTator, text mining | PubMed |
| Genome-Scale CRISPR Screens Reveal DNA Repair Dependencies That Sensitize Hepatocellular Carcinoma to Oxaliplatin. | Cancers (Basel) | 2026 | 42122158 | PubTator, text mining | PubMed |
| A meta-analysis and expression profiling of DNA repair gene polymorphisms in leukemia. | Front Oncol | 2026 | 42109639 | PubTator, text mining | PubMed |
| Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2. | ESMO Open | 2026 | 42105598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2072/papers